Tamara A. Seymour, Director at KEMPHARM, INC (KMPH), bought 200 shares at $4.87 ($974) on 2022-05-20, disclosed to the SEC on 2022-05-24.
Open-market purchase of $974 KMPH by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |